Bruising Fight Looms Over Key Donald Trump Nominees

February 2, 2017

Washington, Feb 2: President Donald Trump has seized a chance to swing the US Supreme Court back to conservative leanings but a drawn-out battle loomed Wednesday over this and other nominations, jarring with his vow to sweep aside politics as usual.

BruisingFight

Trump, in the second week of his already-unorthodox presidency, nominated Judge Neil Gorsuch to replace conservative justice Antonin Scalia, whose death last year sent the Supreme Court rocketing to the top of the list of presidential campaign issues.

"He'll be approved very quickly," Trump declared on Wednesday.

But that confidence belies what looks to be a tough confirmation fight in the Republican-controlled Senate, after Trump's party refused for much of last year to fill the vacant court seat with Barack Obama's nominee.

Trump is pushing for Senate Republicans led by Mitch McConnell to prevent a likely Democratic filibuster by using what is known as the "nuclear option."

That procedure would change Senate rules to push Gorsuch through with a simple majority in the 100-seat chamber rather than a supermajority of 60 votes. Republicans hold 52 Senate seats.

"If we end up with that gridlock I would say, 'If you can, Mitch, go nuclear,'" Trump said on Wednesday.

Senate minority leader Chuck Schumer pushed right back.

"The answer should not be to change the rules of the Senate, but to change the nominee to someone who can earn 60 votes," Schumer said.

McConnell has not revealed whether he would seek to invoke the nuclear option.

The acrimonious row over Trump's ban on travelers from seven Muslim-majority countries has further complicated efforts to get his cabinet nominees confirmed.

Secretary of state pick Rex Tillerson, the former chief executive of ExxonMobil, was expected to be confirmed in a Senate vote Wednesday.

But some Democrats demanded further review of his record. Tillerson "needs to tell us where he stands on this dangerous policy," Senator Martin Heinrich said.

'Governing By Tantrum'

Democrats have vowed to slow-walk confirmation votes on several cabinet nominees.

Their boycott of votes on two Trump picks was dramatically overturned Wednesday when leaders of the Senate finance committee suspended the panel's rules and approved the nominees for Treasury, Steven Mnuchin, and health, Tom Price, with no Democrats present.

Democrats also boycotted a committee vote Wednesday for Scott Pruitt, Trump's choice to head the Environmental Protection Agency.

Republican Senator Jerry Moran, speaking to a half-empty hearing room, described it as "governing by tantrum."

Despite the obstruction, Trump's attorney general pick Jeff Sessions was finally approved by the Senate Judiciary Committee Wednesday following an eight-day delay.

The Supreme Court is likely to be a protracted fight.

If confirmed, Gorsuch would tilt the bench five-to-four in conservatives' favor.

At 49, the silver-haired jurist from Colorado with a flair for writing incisive rulings is the youngest nominee in a generation.

His appointment could have a major impact on cases ranging from business regulation to gender rights to gun control.

'Special Burden'

Gorsuch was a remarkably orthodox pick for a president who has scythed through norms and precedent during his brief time in office.

Like Scalia, Gorsuch is considered an "originalist" -- guided in his legal thinking by the constitution's original intent and meaning.

Democrats warn they will probe carefully to ensure that he holds centrist views and is not intent on rewriting existing law.

Schumer, on the Senate floor, charged that the new administration has shown "less respect for the rule of law than any in recent memory," placing a "special burden on this nominee" to be an independent jurist.

The Supreme Court is the final arbiter of many of the most sensitive issues of US life and law. Its members are named to life terms so their influence is long-lasting.

With an eye to a bitter Congressional fight Gorsuch headed Wednesday to Capitol Hill with Vice President Mike Pence to huddle with McConnell.

"We're all thrilled" with Trump's pick, the Senate majority leader said, as he expressed eagerness to begin the confirmation process.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 14,2020

New Delhi, Apr 14: The World Health Organization on Tuesday lauded "India's tough and timely actions" against the coronavirus spread as Prime Minister Narendra Modi announced the extension of current lockdown till May 3.

"It may be early to talk about results in numbers, but a six-week nationwide lockdown to facilitate effective physical distancing, coupled with the expansion of core public health measures such as detection, isolation and tracing contact of coronavirus positive people, would go a long way in arresting the virus spread," said WHO's South-East Asia Regional Director, Dr Poonam Khetrapal Singh.

"Despite huge and multiple challenges, India has been demonstrating unwavering commitment in its fight against the pandemic," she said.

"In these testing times, the action lies as much with the communities as with the authorities and the health workforce," she added.

"It is indeed time for each and every one to contribute their best and together to beat the virus," Dr Singh said.

Modi on Tuesday said the implementation of the lockdown will be strictly ensured in coming days to ensure that the virus does not spread to new areas

The prime minister said a detailed guideline on the implementation of the new lockdown will be announced on Wednesday.

According the Union Health Ministry figures, a total of 339 people have died of COVIOD-19 till date in the country, while the number of infected cases has soared to 10,363 on Tuesday.

A PTI tally of figures reported by various states as on Monday evening, however, showed at least 346 deaths.

There has been a lag in the Union Health Ministry figures, compared to the number of deaths announced by different states, which officials attribute to procedural delays in assigning the cases to individual states.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
June 28,2020

Paris, Jun 28: More than 10 million cases of the new coronavirus have been officially declared around the world, half of them in Europe and the United States, according to an AFP tally on Sunday based on official sources.

At least 10,003,942 infections, including 498,779 deaths, have been registered globally.

Europe remains the hardest hit continent with 2,637,546 cases including 195,975 fatalities, while the United States has 2,510,323 infections including 125,539 deaths.

The rate of infections worldwide continues to rise, with one million new cases recorded in just six days.

The tallies, using data collected by AFP from national authorities and information from the World Health Organization (WHO), probably reflect only a fraction of the actual number of infections.

Many countries are testing only symptomatic or the most serious cases and some do not have the capacity to carry out widescale testing.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.